Binding of agonists, antagonists and inverse agonists to the human δ-opioid receptor produces distinctly different conformational states distinguishable by plasmon-waveguide resonance spectroscopy
- 11 December 2002
- journal article
- research article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 60 (6) , 322-328
- https://doi.org/10.1034/j.1399-3011.2002.21060.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Plasmon Resonance Studies of Agonist/Antagonist Binding to theHuman δ-Opioid Receptor: New Structural Insights into Receptor-Ligand InteractionsBiophysical Journal, 2000
- (2S,3R)TMT-l-Tic-OH is a potent inverse agonist at the human δ-opioid receptorEuropean Journal of Pharmacology, 1999
- Molecular tinkering of G protein-coupled receptors: an evolutionary successThe EMBO Journal, 1999
- G Protein-coupled ReceptorsJournal of Biological Chemistry, 1998
- The stereochemical requirements of the novel δ-opioid selective dipeptide antagonist TMT-TicBioorganic & Medicinal Chemistry Letters, 1997
- Diversity and Selectivity of Receptor-G Protein InteractionAnnual Review of Pharmacology and Toxicology, 1996
- TIPP[.psi.]: a highly potent and stable pseudopeptide .delta. opioid receptor antagonist with extraordinary .delta. selectivityJournal of Medicinal Chemistry, 1993
- Cloning of a Delta Opioid Receptor by Functional ExpressionScience, 1992
- Receptor-Effector Coupling by G Proteins: Implications for Normal and Abnormal Signal TransductionEndocrine Reviews, 1992
- Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors.Proceedings of the National Academy of Sciences, 1983